Home > Products > HER2 & VEGF
> Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Fv-IgG)
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Fv-IgG) (CAT#: BSDG-168)
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-HER2 IgG with similar domains from an anti-VEGF antibody via short peptide linkers, or vice versa. This BsAb can bind two factors simultaneously and inhibit cell proliferation. It is designed for the research of Colorectal cancer; Breast cancer; Lung cancer; Renal cell cancer (RCC); Glioma cancer; Glioblastoma; Ovarian cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Fv-IgG) (BSDG-168). Click the button below to contact us or submit your feedback about this product.